Skip to main content

Qiming Venture Partners — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

399
Companies
$13.8B
Total invested
$52.1M
Avg. check
40
Industries
Biotechnology 10Medical 9Health Care 7Therapeutics 6Pharmaceutical 5Life Science 5+34 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 1–24 of 399
Satellos Bioscience
September 2025

Satellos Bioscience is a private regenerative medicine company developing novel therapeutics that stimulate or restore muscle regeneration.

Health Care · Toronto$754K Post-IPO Equity
Swift Bridge Technologies
August 2025

Swift Bridge Technologies designs and produces quality and cost efficient cable assemblies.

Electronics · Tigard$1.0M Venture - Series Unknown
AusperBio
August 2026

AusperBio is a biotechnology company focused on developing oligonucleotide therapeutics and targeted delivery technologies.

Biopharma · San Mateo$120.0M Series C
WAM Bio
August 2025

WAM Bio is a company operating in stealth mode.

Dover$1.5M Seed
Sesame Therapeutics
July 2025

Sesame Therapeutics is a healthcare company that provides precision oncology medicines with therapeutic windows.

Medical · Plymouth$19.0M Series A
P0x Labs
July 2023

P0x Labs is the team behind Manta Network is a privacy-preserving technology operating on the Polkadot blockchain.

Blockchain · Boston$25.0M Series A
AskGene Pharma
July 2023

AskGene Pharma is a pharmaceuticals company.

Biotechnology · CamarilloSeries A
Sharpa
July 2025

Sharpa is a robotics company that develops robots and core robotic components for real-world deployment of robotic applications.

Artificial Intelligence (AI) · Singapore$100.0M Series A
Boulder Care
July 2026

Boulder is a telehealth provider of treatment and long-term support for people with substance use disorders

Health Care · Portland$1.8M Grant
TigerGraph
July 2025

TigerGraph supports advanced analytics and machine learning platforms through its distributed native graph database.

Analytics · Redwood CityVenture - Series Unknown
NEIWAI
July 2021

NEIWAI specializes in making comfortable underwear, loungewear, and athleisure with an emphasis on technology and innovation.

Consumer Goods · San Francisco$100.0M Series D
Renasant Bio
July 2025

Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments.

Biotechnology · Berkeley$54.5M Seed
Elevation Oncology
June 2023

Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.

Biopharma · New York$50.0M Post-IPO Equity
Entact Bio
June 2026

Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function.

Biopharma · Watertown$10.0M Venture - Series Unknown
Leyden Labs
June 2026

Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.

Biotechnology · Amsterdam$45.4M Undisclosed
InfStones
June 2022

InfStones provides decentralized blockchain infrastructure service on one integrated platform.

Blockchain · Palo Alto$66.0M Series C
LTZ Therapeutics
May 2026

LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.

Biotechnology · San Francisco$38.0M Venture - Series Unknown
Windward Bio
May 2026

Windward Bio develops monoclonal antibodies for advanced immunological diseases.

Biotechnology · Basel$165.0M Series B
BUD
May 2022

BUD is an open metaverse gaming platform that connects millions of virtual worlds created by our community, made up of 9 million creators.

3D Technology · Singapore$37.0M Series B
Aureka Biotechnologies
April 2026

Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.

Biotechnology · Laguna Hills$35.0M Series A
Vivatides Therapeutics
April 2026

Vivatides Therapeutics develops RNA treatments to help improve patients' lives using biotechnology research.

Biotechnology · Woburn$54.0M Series A
BlockVision
March 2022

BlockVision is a high-availability indexing network, supporting complex queries and data analysis.

Cryptocurrency · Singapore$5.0M Seed
Neuro3 Therapeutics
March 2025

Neuro3 Therapeutics is a Hong Kong based company that advances medicines for CNS diseases.

Medical · Hong Kong$3.5M Seed
moodytiger
March 2023

moodytiger is a technical athletic apparel brand for children from age of 4 to 16.

Apparel · Hong KongConvertible Note

Where Qiming Venture Partners invests

Biotechnology10
Medical9
Health Care7
Therapeutics6
Pharmaceutical5
Life Science5

About Qiming Venture Partners's portfolio

How many companies has Qiming Venture Partners invested in?▸

Qiming Venture Partners has invested in 399 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Qiming Venture Partners invest in?▸

Qiming Venture Partners's top investment sectors include Biotechnology, Medical, Health Care, Therapeutics, Pharmaceutical. The firm invests across 40 different industry categories.

What is Qiming Venture Partners's largest investment?▸

Among tracked funding rounds, Windward Bio received $165.0M in a Series B round. Qiming Venture Partners's total known invested capital is $13.8B.

What is the average investment size for Qiming Venture Partners?▸

Qiming Venture Partners's average investment size is $52.1M across its portfolio of 399 companies.

What are Qiming Venture Partners's most recent investments?▸

Recent Qiming Venture Partners portfolio additions include Satellos Bioscience, Swift Bridge Technologies, AusperBio, WAM Bio, Sesame Therapeutics. These companies were founded in 2020 or later.

Reach the founders behind these 399 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →